DQR MedTech is the industry leader in driving successful regulatory submissions and outcomes through effective, daily interactions with the USFDA, CDSCO, TGA, Taiwan, Invima, Japan’s PMDA, Europe’s Notified Bodies, China’s NMPA and other international authorities.
We provide a wide range of regulatory services across the full spectrum of product design and development through post-market support. From Notified Body selection and Pre-IDE preparation to Advisory Panel Meetings, our experts develop and implement global regulatory strategies to accelerate your specific commercialization efforts—ultimately getting you to market faster so you may make a more immediate impact on patient safety and healthcare.
